Adebowale Adeniran

4.3k total citations · 1 hit paper
103 papers, 2.5k citations indexed

About

Adebowale Adeniran is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Adebowale Adeniran has authored 103 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 41 papers in Surgery and 30 papers in Molecular Biology. Recurrent topics in Adebowale Adeniran's work include Renal cell carcinoma treatment (28 papers), Thyroid Cancer Diagnosis and Treatment (22 papers) and Renal and related cancers (21 papers). Adebowale Adeniran is often cited by papers focused on Renal cell carcinoma treatment (28 papers), Thyroid Cancer Diagnosis and Treatment (22 papers) and Renal and related cancers (21 papers). Adebowale Adeniran collaborates with scholars based in United States, China and Canada. Adebowale Adeniran's co-authors include Harriet M. Kluger, Brian Shuch, Yuri E. Nikiforov, Manju L. Prasad, David L. Steward, Manoj Gandhi, Zhaowen Zhu, James P. Fidler, Thomas J. Giordano and Paul W. Biddinger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Adebowale Adeniran

100 papers receiving 2.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial

2021 170 citations Brian Shuch, Peter A. Humphrey et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adebowale Adeniran United States	25	978	800	793	733	697	103	2.5k
Nancy P. Caraway United States	28	673 0.7×	634 0.8×	352 0.4×	790 1.1×	596 0.9×	82	2.3k
Jocelyn Migliacci United States	24	465 0.5×	405 0.5×	416 0.5×	1.3k 1.8×	922 1.3×	46	3.0k
Lucio Palombini Italy	25	363 0.4×	663 0.8×	978 1.2×	768 1.0×	786 1.1×	92	2.6k
Tatjana Antic United States	33	2.1k 2.1×	682 0.9×	392 0.5×	789 1.1×	470 0.7×	135	3.3k
Aaron M. Udager United States	26	605 0.6×	682 0.9×	217 0.3×	983 1.3×	510 0.7×	126	2.0k
Kamal K. Khurana United States	24	471 0.5×	289 0.4×	431 0.5×	622 0.8×	502 0.7×	75	1.7k
Oscar Nappi Italy	26	852 0.9×	537 0.7×	186 0.2×	552 0.8×	1.2k 1.7×	70	2.2k
Elena Vigliar Italy	27	693 0.7×	375 0.5×	217 0.3×	364 0.5×	762 1.1×	105	1.8k
Immacolata Cozzolino Italy	23	490 0.5×	321 0.4×	262 0.3×	621 0.8×	444 0.6×	116	1.7k
David Poller United Kingdom	26	433 0.4×	349 0.4×	613 0.8×	948 1.3×	944 1.4×	78	3.0k

Countries citing papers authored by Adebowale Adeniran

Since Specialization

Citations

This map shows the geographic impact of Adebowale Adeniran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adebowale Adeniran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adebowale Adeniran more than expected).

Fields of papers citing papers by Adebowale Adeniran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adebowale Adeniran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adebowale Adeniran. The network helps show where Adebowale Adeniran may publish in the future.

Co-authorship network of co-authors of Adebowale Adeniran

This figure shows the co-authorship network connecting the top 25 collaborators of Adebowale Adeniran. A scholar is included among the top collaborators of Adebowale Adeniran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adebowale Adeniran. Adebowale Adeniran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Haiming, et al.. (2025). Clinicopathologic characteristics of lymphoproliferative disorders involving the kidney. American Journal of Clinical Pathology. 164(2). 192–199.

Jilaveanu, Lucia B., Adebowale Adeniran, David Su, et al.. (2024). TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3. Cancer Immunology Immunotherapy. 73(10). 192–192. 2 indexed citations

Mann, Jacqueline E., David Su, Adebowale Adeniran, et al.. (2024). GP100 expression is variable in intensity in melanoma. Cancer Immunology Immunotherapy. 73(10). 191–191. 3 indexed citations

Abi‐Raad, Rita, Manju L. Prasad, Adebowale Adeniran, & Guoping Cai. (2022). Copy number variations identified in thyroid FNA specimens are associated with Hürthle cell cytomorphology. Cancer Cytopathology. 130(6). 415–422. 5 indexed citations

Manucha, Varsha, Adebowale Adeniran, Rana S. Hoda, et al.. (2022). High-risk human papillomavirus testing in cytology aspiration samples from the head and neck part 1: a review of the literature on available testing options. Journal of the American Society of Cytopathology. 11(5). 295–305. 5 indexed citations

Wang, Minhua, et al.. (2021). Expression of insulinoma-associated protein 1 in non–small cell lung cancers: a diagnostic pitfall for neuroendocrine tumors. Human Pathology. 115. 104–111. 7 indexed citations

Gilani, Syed M., Rita Abi‐Raad, James Garritano, et al.. (2021). RAS mutation and associated risk of malignancy in the thyroid gland: An FNA study with cytology‐histology correlation. Cancer Cytopathology. 130(4). 284–293. 18 indexed citations

Gilani, Syed M., et al.. (2020). Molecular alterations in Hürthle cell neoplasms of thyroid: A fine needle aspiration cytology study with cytology‐histology correlation. Cancer Cytopathology. 129(5). 363–373. 9 indexed citations

Darbinyan, Armine, Raffaella Morotti, Guoping Cai, et al.. (2020). Cytomorphologic features of thyroid disease in patients with DICER1 mutations: A report of cytology–histopathology correlation in 7 patients. Cancer Cytopathology. 128(10). 746–756. 16 indexed citations

10.

Abi‐Raad, Rita, Manju L. Prasad, Syed M. Gilani, et al.. (2020). Quantitative assessment of p16 expression in FNA specimens from head and neck squamous cell carcinoma and correlation with HPV status. Cancer Cytopathology. 129(5). 394–404. 13 indexed citations

11.

Abi‐Raad, Rita, Manju L. Prasad, Adebowale Adeniran, & Guoping Cai. (2020). Fine‐needle aspiration cytomorphology of papillary thyroid carcinoma with NTRK gene rearrangement from a case series with predominantly indeterminate cytology. Cancer Cytopathology. 128(11). 803–811. 7 indexed citations

12.

Ueno, Daiki, Zuoquan Xie, Marta Boeke, et al.. (2018). Genomic Heterogeneity and the Small Renal Mass. Clinical Cancer Research. 24(17). 4137–4144. 13 indexed citations

13.

Jilaveanu, Lucia B., Mäneka Puligandla, Sarah A. Weiss, et al.. (2017). Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805. Clinical Cancer Research. 24(1). 217–223. 24 indexed citations

14.

Kluger, Harriet M., Christopher R. Zito, Gabriela Turcu, et al.. (2017). PD-L1 Studies Across Tumor Types, Its Differential Expression and Predictive Value in Patients Treated with Immune Checkpoint Inhibitors. Clinical Cancer Research. 23(15). 4270–4279. 111 indexed citations

15.

Prasad, Manju L., et al.. (2017). Identification of distinct cytomorphologic features in the diagnosis of NIFTP at the time of preoperative FNA: Implications for patient management. Cancer Cytopathology. 125(11). 865–875. 22 indexed citations

16.

Peterß, Sven, Ahmed M. Mansour, Paris Charilaou, et al.. (2016). Changing Pathology of the Thoracic Aorta From Acute to Chronic Dissection. Journal of the American College of Cardiology. 68(10). 1054–1065. 108 indexed citations

17.

Virk, Renu K., Pei Hui, Avīnash Prasad, et al.. (2013). Tall Cell Variant of Papillary Thyroid Microcarcinoma: Clinicopathologic Features with BRAF ^V600E Mutational Analysis. Thyroid. 23(12). 1525–1531. 36 indexed citations

18.

Adeniran, Adebowale, Constantine Theoharis, Pei Hui, et al.. (2011). Reflex BRAF Testing in Thyroid Fine-Needle Aspiration Biopsy with Equivocal and Positive Interpretation: A Prospective Study. Thyroid. 21(7). 717–723. 50 indexed citations

19.

Huang, Qin, Raj K. Goyal, Adebowale Adeniran, et al.. (2007). Genitourinary. Modern Pathology. 20. 133–186. 1 indexed citations

20.

Stanek, Jerzy & Adebowale Adeniran. (2006). Chorion Nodosum: A Placental Feature of the Severe Early Amnion Rupture Sequence. Pediatric and Developmental Pathology. 9(5). 353–360. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact